| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +10.77% | +5.01% | +5.76% | +5.76% | — |
| 14d | 2 | +100.00% | +15.67% | +3.10% | +12.57% | +12.57% | — |
| 30d | 2 | +100.00% | +25.06% | +11.26% | +0.85% | +0.85% | — |
| 60d | 2 | +100.00% | +41.89% | +10.62% | +31.28% | +31.28% | — |
| 90d | 2(1 pending) | +100.00% | +68.15% | +23.06% | +45.09% | +45.09% | — |
| 180d | 2(1 pending) | +100.00% | +135.67% | +32.68% | +102.99% | +102.99% | — |
| 1y | 2(1 pending) | +100.00% | +238.22% | +30.70% | +207.52% | +207.52% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 25,000 | $1.89 | $47.3K | 196,000 | Apr 29, 2026 | Apr 29, 2026 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASE General Counsel | 25,000 | $1.89 | $47.3K | 196,000 | Apr 29, 2026 | Apr 30, 2026 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 720,000 | — | — | 720,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | $5.17 | $775.5K | 171,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASE Gen Counsel & Corporate Sec | 20,000 | $1.54 | $30.8K | 21,000 | Apr 7, 2025 | Apr 8, 2025 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 280,000 | — | — | 280,000 | Feb 11, 2025 | Feb 13, 2025 ↗ | View → |
| CMPX COMPASS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Aug 13, 2024 | Aug 14, 2024 ↗ | View → |